Cariprazine was recently approved for the treatment of bipolar I disorder (BPI) and schizophrenia (SZ) in Canada.
View this informative and interactive session where Dr. Cutler shares his clinical trial and real-life experiences.
CLICK HERE TO VIEW RECORDING
Presenter
Andrew J CutlerMD
Presentation in English
Andrew J CutlerMD
Presentation in English
Moderator
Theodore KolivakisMD, FRCPC
Presentation in English
Theodore KolivakisMD, FRCPC
Presentation in English
This event was organized by the CPD Network, a not-for-profit physician organization,
who received an educational grant from AbbVie Canada.